400 related articles for article (PubMed ID: 25862012)
1. Dolutegravir Has No Effect on the Pharmacokinetics of Oral Contraceptives With Norgestimate and Ethinyl Estradiol.
Song IH; Borland J; Chen S; Wajima T; Peppercorn AF; Piscitelli SC
Ann Pharmacother; 2015 Jul; 49(7):784-9. PubMed ID: 25862012
[TBL] [Abstract][Full Text] [Related]
2. The effect of atazanavir/ritonavir on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy women.
Zhang J; Chung E; Yones C; Persson A; Mahnke L; Eley T; Xu X; Bertz R
Antivir Ther; 2011; 16(2):157-64. PubMed ID: 21447864
[TBL] [Abstract][Full Text] [Related]
3. The effect of efavirenz on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy HIV-negative women.
Sevinsky H; Eley T; Persson A; Garner D; Yones C; Nettles R; Krantz K; Bertz R; Zhang J
Antivir Ther; 2011; 16(2):149-56. PubMed ID: 21447863
[TBL] [Abstract][Full Text] [Related]
4. Effect of laropiprant, a PGD2 receptor 1 antagonist, on estradiol and norgestimate pharmacokinetics after oral contraceptive administration in women.
Schwartz JI; Liu F; Wang YH; Pramanik B; Johnson-Levonas AO; Gutierrez MJ; Lai E; Wagner JA
Am J Ther; 2009; 16(6):487-95. PubMed ID: 19940609
[TBL] [Abstract][Full Text] [Related]
5. Lack of a clinically important pharmacokinetic interaction between sofosbuvir or ledipasvir and hormonal oral contraceptives norgestimate/ethinyl estradiol in HCV-uninfected female subjects.
German P; Moorehead L; Pang P; Vimal M; Mathias A
J Clin Pharmacol; 2014 Nov; 54(11):1290-8. PubMed ID: 24925712
[TBL] [Abstract][Full Text] [Related]
6. The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 micro g ethinyl estradiol versus monophasic levonorgestrel/20 micro g ethinyl estradiol.
Creinin MD; Lippman JS; Eder SE; Godwin AJ; Olson W
Contraception; 2002 Sep; 66(3):147-52. PubMed ID: 12384201
[TBL] [Abstract][Full Text] [Related]
7. A Multi-Center, Open-Label, Pharmacokinetic Drug Interaction Study of Erenumab and a Combined Oral Contraceptive in Healthy Females.
Xu Y; Gabriel K; Wang Y; Zhou Y; Eisele O; Vutikullird A; Mikol DD; Lee E
CNS Drugs; 2019 May; 33(5):513-522. PubMed ID: 30963506
[TBL] [Abstract][Full Text] [Related]
8. Absence of effect of oral rifaximin on the pharmacokinetics of ethinyl estradiol/norgestimate in healthy females.
Trapnell CB; Connolly M; Pentikis H; Forbes WP; Bettenhausen DK
Ann Pharmacother; 2007 Feb; 41(2):222-8. PubMed ID: 17284510
[TBL] [Abstract][Full Text] [Related]
9. Effect of the coadministration of daclatasvir on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate.
Bifano M; Sevinsky H; Hwang C; Kandoussi H; Jiang H; Grasela D; Bertz R
Antivir Ther; 2014; 19(5):511-9. PubMed ID: 24343001
[TBL] [Abstract][Full Text] [Related]
10. Effect of raltegravir on estradiol and norgestimate plasma pharmacokinetics following oral contraceptive administration in healthy women.
Anderson MS; Hanley WD; Moreau AR; Jin B; Bieberdorf FA; Kost JT; Wenning LA; Stone JA; Wagner JA; Iwamoto M
Br J Clin Pharmacol; 2011 Apr; 71(4):616-20. PubMed ID: 21395656
[TBL] [Abstract][Full Text] [Related]
11. Effects of rimegepant 75 mg daily on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate in healthy female participants.
Bhardwaj R; Stringfellow JC; Morris B; Croop RS; Bertz RJ
Headache; 2023 May; 63(5):652-662. PubMed ID: 37140071
[TBL] [Abstract][Full Text] [Related]
12. The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone.
Hendrix CW; Jackson KA; Whitmore E; Guidos A; Kretzer R; Liss CM; Shah LP; Khoo KC; McLane J; Trapnell CB
Clin Pharmacol Ther; 2004 May; 75(5):464-75. PubMed ID: 15116059
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Potential Drug-Drug Interaction Between Delayed-Release Dimethyl Fumarate and a Commonly Used Oral Contraceptive (Norgestimate/Ethinyl Estradiol) in Healthy Women.
Zhu B; Nestorov I; Zhao G; Meka V; Leahy M; Kam J; Sheikh SI
Clin Pharmacol Drug Dev; 2017 Nov; 6(6):604-613. PubMed ID: 28783872
[TBL] [Abstract][Full Text] [Related]
14. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
[TBL] [Abstract][Full Text] [Related]
15. Lack of effect of oral cabotegravir on the pharmacokinetics of a levonorgestrel/ethinyl oestradiol-containing oral contraceptive in healthy adult women.
Trezza C; Ford SL; Gould E; Lou Y; Huang C; Ritter JM; Buchanan AM; Spreen W; Patel P
Br J Clin Pharmacol; 2017 Jul; 83(7):1499-1505. PubMed ID: 28087972
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic overview of Ortho Evra/Evra.
Abrams LS; Skee D; Natarajan J; Wong FA
Fertil Steril; 2002 Feb; 77(2 Suppl 2):S3-12. PubMed ID: 11849630
[TBL] [Abstract][Full Text] [Related]
17. Effect of saxagliptin on the pharmacokinetics of the active components of Ortho-Cyclen(®), a combined oral contraceptive containing ethinyl estradiol and norgestimate, in healthy women.
Upreti VV; Hsiang CB; Li L; Xu X; LaCreta FP; Boulton DW
Diabetes Obes Metab; 2012 Dec; 14(12):1155-7. PubMed ID: 22776778
[TBL] [Abstract][Full Text] [Related]
18. Influence of alitretinoin on the pharmacokinetics of the oral contraceptive ethinyl estradiol/norgestimate.
Schmitt-Hoffmann AH; Roos B; Sauer J; Schleimer M; Schoetzau A; Leese PT; Weidekamm E; Maares J
Clin Exp Dermatol; 2011 Apr; 36 Suppl 2():4-11. PubMed ID: 21443598
[TBL] [Abstract][Full Text] [Related]
19. Lack of effect of tenofovir disoproxil fumarate on pharmacokinetics of hormonal contraceptives.
Kearney BP; Mathias A
Pharmacotherapy; 2009 Aug; 29(8):924-9. PubMed ID: 19637945
[TBL] [Abstract][Full Text] [Related]
20. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
Griffith SG; Dai Y
Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
